ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $232,027 | -31.5% | 10,663 | -2.4% | 0.00% | – |
| Q4 2022 | $338,658 | +22.7% | 10,928 | +0.7% | 0.00% | – |
| Q3 2022 | $276,000 | -29.8% | 10,848 | -44.1% | 0.00% | – |
| Q2 2022 | $393,000 | +3.4% | 19,402 | +26.2% | 0.00% | – |
| Q1 2022 | $380,000 | -49.6% | 15,373 | -29.2% | 0.00% | – |
| Q4 2021 | $754,000 | +222.2% | 21,700 | +423.4% | 0.00% | – |
| Q2 2019 | $234,000 | -50.6% | 4,146 | -36.1% | 0.00% | – |
| Q1 2019 | $474,000 | +115.5% | 6,491 | +88.2% | 0.00% | – |
| Q4 2018 | $220,000 | -69.3% | 3,449 | -52.0% | 0.00% | -100.0% |
| Q3 2018 | $717,000 | +192.7% | 7,189 | +108.4% | 0.00% | – |
| Q2 2018 | $245,000 | -61.5% | 3,450 | -43.6% | 0.00% | -100.0% |
| Q1 2018 | $637,000 | +90.7% | 6,112 | +84.2% | 0.00% | – |
| Q4 2017 | $334,000 | – | 3,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |